A noticeable point arising from this study is that high levels of NEDD9 expression were associated with the aggressive breast cancers, including TNBC and ERBB2-overexpressing subtypes (Fig. 1, Table 1; Table S1). This evidence concerns the gene NEDD9 and breast carcinoma.